| Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients JJ Popma, GM Deeb, SJ Yakubov, M Mumtaz, H Gada, D O’Hair, T Bajwa, ... New England Journal of Medicine 380 (18), 1706-1715, 2019 | 3300 | 2019 |
| Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study H Krum, M Schlaich, R Whitbourn, PA Sobotka, J Sadowski, K Bartus, ... The Lancet 373 (9671), 1275-1281, 2009 | 3226 | 2009 |
| Percutaneous closure of patent foramen ovale in cryptogenic embolism B Meier, B Kalesan, HP Mattle, AA Khattab, D Hildick-Smith, D Dudek, ... New England Journal of Medicine 368 (12), 1083-1091, 2013 | 1073 | 2013 |
| Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept … DE Kandzari, M Böhm, F Mahfoud, RR Townsend, MA Weber, S Pocock, ... The Lancet 391 (10137), 2346-2355, 2018 | 835 | 2018 |
| Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled … RR Townsend, F Mahfoud, DE Kandzari, K Kario, S Pocock, MA Weber, ... The Lancet 390 (10108), 2160-2170, 2017 | 806 | 2017 |
| Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept MP Schlaich, PA Sobotka, H Krum, R Whitbourn, A Walton, MD Esler Hypertension 54 (6), 1195-1201, 2009 | 558 | 2009 |
| Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012 | 481 | 2012 |
| Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension D Hering, EA Lambert, P Marusic, AS Walton, H Krum, GW Lambert, ... Hypertension 61 (2), 457-464, 2013 | 422 | 2013 |
| Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure J Ritzema, R Troughton, I Melton, I Crozier, R Doughty, H Krum, A Walton, ... Circulation 121 (9), 1086-1095, 2010 | 354 | 2010 |
| Early experience with new transcatheter mitral valve replacement V Bapat, V Rajagopal, C Meduri, RS Farivar, A Walton, SJ Duffy, R Gooley, ... Journal of the American College of Cardiology 71 (1), 12-21, 2018 | 278 | 2018 |
| Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system G Manoharan, AS Walton, SJ Brecker, S Pasupati, DJ Blackman, H Qiao, ... Cardiovascular Interventions 8 (10), 1359-1367, 2015 | 248 | 2015 |
| Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial F Mahfoud, DE Kandzari, K Kario, RR Townsend, MA Weber, ... The Lancet 399 (10333), 1401-1410, 2022 | 186 | 2022 |
| Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? MC Nguyen, YL Lim, A Walton, J Lefkovits, G Agnelli, SG Goodman, ... European heart journal 28 (14), 1717-1722, 2007 | 172 | 2007 |
| Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease MP Schlaich, B Bart, D Hering, A Walton, P Marusic, F Mahfoud, M Böhm, ... International journal of cardiology 168 (3), 2214-2220, 2013 | 170 | 2013 |
| Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the international FORWARD study E Grube, NM Van Mieghem, S Bleiziffer, T Modine, J Bosmans, ... Journal of the American College of Cardiology 70 (7), 845-853, 2017 | 167 | 2017 |
| One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated … SJ Shah, T Feldman, MJ Ricciardi, R Kahwash, S Lilly, S Litwin, ... JAMA cardiology 3 (10), 968-977, 2018 | 155 | 2018 |
| Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension D Hering, P Marusic, AS Walton, EA Lambert, H Krum, K Narkiewicz, ... Hypertension 64 (1), 118-124, 2014 | 151 | 2014 |
| One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction DM Kaye, G Hasenfuss, P Neuzil, MC Post, R Doughty, JN Trochu, ... Circulation: Heart Failure 9 (12), e003662, 2016 | 144 | 2016 |
| Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure L Søndergaard, V Reddy, D Kaye, F Malek, A Walton, M Mates, O Franzen, ... European journal of heart failure 16 (7), 796-801, 2014 | 142 | 2014 |
| Percutaneous method of laser transmyocardial revascularization CB Kim, R Kesten, M Javier, M Hayase, AS Walton, ME Billingham, ... Catheterization and cardiovascular diagnosis 40 (2), 223-228, 1997 | 123 | 1997 |
